Hendrix Genetics and Sofiprotéol have signed and completed an agreement in which:
(a) Sofiprotéol acquired 12% of the outstanding share capital and related voting rights in Hendrix Genetics B.V. and becomes a long term strategic shareholder,
(b) formed a strategic alliance in which the parties will focus on growth and consolidation opportunities in global animal breeding and life sciences and,
(c) Hendrix Genetics S.A.S. acquired France Hybrides S.A.S, a famous French swine genetics company, from Groupe Glon. It will be integrated in its swine genetics division Hypor.